OtherArticle
Drug-interaction potential of LK-935, the novel non-statin type cholesterol lowering agent
Katalin Monostory, Jean-Marc Pascussi, Pal Szabo, Manna Temesvari, Krisztina Kohalmy, Jure Acimovic, Darko Kocjan, Drago Kuzman, Britta Wilzewski, Rita Bernhardt, Laszlo Kobori and Damjana Rozman
Drug Metabolism and Disposition October 29, 2008, DOI: https://doi.org/10.1124/dmd.108.023887
Katalin Monostory
Jean-Marc Pascussi
Pal Szabo
Manna Temesvari
Krisztina Kohalmy
Jure Acimovic
Darko Kocjan
Drago Kuzman
Britta Wilzewski
Rita Bernhardt
Laszlo Kobori
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Drug-interaction potential of LK-935, the novel non-statin type cholesterol lowering agent
Katalin Monostory, Jean-Marc Pascussi, Pal Szabo, Manna Temesvari, Krisztina Kohalmy, Jure Acimovic, Darko Kocjan, Drago Kuzman, Britta Wilzewski, Rita Bernhardt, Laszlo Kobori and Damjana Rozman
Drug Metabolism and Disposition October 29, 2008, DOI: https://doi.org/10.1124/dmd.108.023887
OtherArticle
Drug-interaction potential of LK-935, the novel non-statin type cholesterol lowering agent
Katalin Monostory, Jean-Marc Pascussi, Pal Szabo, Manna Temesvari, Krisztina Kohalmy, Jure Acimovic, Darko Kocjan, Drago Kuzman, Britta Wilzewski, Rita Bernhardt, Laszlo Kobori and Damjana Rozman
Drug Metabolism and Disposition October 29, 2008, DOI: https://doi.org/10.1124/dmd.108.023887
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement